Harsh Organo-Chem (India) Profile
Key Indicators
- Authorised Capital ₹ 2.25 Cr
as on 08-12-2024
- Paid Up Capital ₹ 1.81 Cr
as on 08-12-2024
- Company Age 21 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 50.69 Cr
as on 08-12-2024
- Satisfied Charges ₹ 4.95 Cr
as on 08-12-2024
- Revenue 5.72%
(FY 2022)
- Profit 292.61%
(FY 2022)
- Ebitda -10.29%
(FY 2022)
- Net Worth 2.25%
(FY 2022)
- Total Assets 18.27%
(FY 2022)
About Harsh Organo-Chem (India)
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.25 Cr and a paid-up capital of Rs 1.81 Cr.
The company currently has active open charges totaling ₹50.69 Cr. The company has closed loans amounting to ₹4.95 Cr, as per Ministry of Corporate Affairs (MCA) records.
Suketu Shah and Rishilkumar Shah serve as directors at the Company.
- CIN/LLPIN
U24116GJ2003PTC042761
- Company No.
042761
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Aug 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Harsh Organo-Chem (India)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rishilkumar Shah  | Additional Director | 23-Oct-2024 | Current |
| Suketu Shah | Director | 01-Sep-2004 | Current |
Financial Performance and Corporate Structure Insights of Harsh Organo-Chem (India).
Harsh Organo-Chem (India) Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 5.72% increase. The company also saw a substantial improvement in profitability, with a 292.61% increase in profit. The company's net worth moved up by a moderate rise of 2.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Harsh Organo-Chem (India)?
In 2023, Harsh Organo-Chem (India) had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Zil Organics Private LimitedActive 5 years 5 days
Suketu Shah and Rishilkumar Shah are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 31 Jul 2021 | ₹2.42 M | Open |
Hdfc Bank Limited Creation Date: 21 Feb 2015 | ₹3.75 Cr | Open |
Hdfc Bank Limited Creation Date: 21 Feb 2015 | ₹3.00 Cr | Open |
How Many Employees Work at Harsh Organo-Chem (India)?
Unlock and access historical data on people associated with Harsh Organo-Chem (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Harsh Organo-Chem (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Harsh Organo-Chem (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
